Home > Insider Trading > Filing (0001209191-14-038854)

Filing Details

Accession Number:: 0001209191-14-038854
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-03 21:28:37
Reporting Period:: 2014-04-03

Filing Date:: 2014-06-03
Accepted Time:: 2014-06-03 21:28:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1266275	Kate Mitchell	950 Tower Lane, Suite 700 Foster City CA 94404	No	No	Yes	No
1308328	Bavp, L.p.	950 Tower Lane, Suite 700 Foster City CA 94404	No	No	Yes	No
1308343	Scale Venture Management I, Llc	950 Tower Lane, Suite 700 Foster City CA 94404	No	No	Yes	No
1366969	Rory O'driscoll	950 Tower Lane, Suite 700 Foster City CA 94404	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-04-03	14,500	$7.47	4,848,594	No	4	S	Direct
Common Stock	Disposition	2014-04-04	10,969	$7.22	4,837,625	No	4	S	Direct
Common Stock	Disposition	2014-04-07	26,400	$6.60	4,811,225	No	4	S	Direct
Common Stock	Disposition	2014-04-08	22,900	$6.48	4,788,325	No	4	S	Direct
Common Stock	Disposition	2014-04-09	18,400	$6.64	4,769,925	No	4	S	Direct
Common Stock	Disposition	2014-04-10	7,800	$6.48	4,762,125	No	4	S	Direct
Common Stock	Disposition	2014-04-11	23,000	$6.57	4,739,125	No	4	S	Direct
Common Stock	Disposition	2014-04-14	13,300	$6.29	4,725,825	No	4	S	Direct
Common Stock	Disposition	2014-04-15	7,000	$6.28	4,718,825	No	4	S	Direct
Common Stock	Disposition	2014-04-16	10,900	$6.27	4,707,925	No	4	S	Direct
Common Stock	Disposition	2014-04-17	13,700	$6.30	4,694,225	No	4	S	Direct
Common Stock	Disposition	2014-04-21	9,500	$6.26	4,684,725	No	4	S	Direct
Common Stock	Disposition	2014-04-22	17,700	$6.27	4,667,025	No	4	S	Direct
Common Stock	Disposition	2014-04-24	300	$6.25	4,666,725	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 trading plan.
The shares were sold at prices ranging from $7.41 to $7.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). Kate Mitchell and Rory O'Driscoll are the managing members of Scale and share voting and investment power with respect to these shares. Each of the managing members of Scale disclaims beneficial ownership with respect to these shares except to the extent of their pecuniary interest therein.
The shares were sold at prices ranging from $7.08 to $7.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.43 to $6.92. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.35 to $6.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.41 to $6.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.42 to $6.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $6.25 to $6.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.